SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-19-264542
Filing Date
2019-10-08
Accepted
2019-10-08 17:25:50
Documents
69
Period of Report
2019-08-31

Document Format Files

Seq Description Document Type Size
1 10-Q d803215d10q.htm 10-Q 424575
2 EX-31.1 d803215dex311.htm EX-31.1 11061
3 EX-31.2 d803215dex312.htm EX-31.2 11053
4 EX-32.1 d803215dex321.htm EX-32.1 4398
5 EX-32.2 d803215dex322.htm EX-32.2 4376
  Complete submission text file 0001193125-19-264542.txt   5511269

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT cydy-20190831.xml EX-101.INS 1019501
7 XBRL TAXONOMY EXTENSION SCHEMA cydy-20190831.xsd EX-101.SCH 73207
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cydy-20190831_cal.xml EX-101.CAL 34359
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cydy-20190831_def.xml EX-101.DEF 507061
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE cydy-20190831_lab.xml EX-101.LAB 512905
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cydy-20190831_pre.xml EX-101.PRE 527663
Mailing Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660
Business Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660 360-980-8524
CytoDyn Inc. (Filer) CIK: 0001175680 (see all company filings)

IRS No.: 753056237 | State of Incorp.: DE | Fiscal Year End: 0531
Type: 10-Q | Act: 34 | File No.: 000-49908 | Film No.: 191143340
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences